 |
Original Paper
Pharmacology | Planta Med 2005; 71: 202-207 DOI: 10.1055/s-2005-837817 |
© Georg Thieme Verlag KG Stuttgart · New York |
| |
 |
Protopanaxatriol-Type Ginsenosides Differentially Modulate Type 1 and Type 2 Cytokines Production from Murine Splenocytes |
| |
| Jun-Li Yu1, De-Qiang Dou2, Xiao-Hong Chen1, Hong-Zhen Yang1, Na Guo2, Gui-Fang Cheng1 |
1 Department of Pharmacology, Institute of Materia Medica, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, P. R. China
2 Department of Natural Products Chemistry, Shenyang Pharmaceutical University, Shenyang, P. R. China |
Abstract
Seven protopanaxatriol-type ginsenosides and their aglycones including PPT, PT, -Re, -Rg1, -F1, -Rh1, 20(R)-Rh1 which are closely related in structure were studied for their effects on type 1 and type 2 cytokines production from murine splenocytes and their related mechanisms were examined. The results indicate that PPT, PT and ginsenoside-Re show hardly any or weak effects on concanavalin A (Con A)-induced production of IFN-γ and IL-4. Ginsenoside-Rh1 and 20(R)-Rh1 induce a Con A-induced type 1 cytokine pattern by increasing the production of interleukin-12 (IL-12), the expression of IFN-γ, T-bet and enhancing NF-κB DNA binding activity. In contrast ginsenosides-Rg1 and -F1 cause a Con A-induced type 2 cytokines response by increasing the expression of IL-4, GATA-3 and enhancing NF-κB DNA binding activity. Thus, these protopanaxatriol-type ginsenosides have different immunomodulatory effects, which might explain the complex immunomodulatory effect of Panax ginseng.
Key words
Ginsenosides - interferon-γ (IFN-γ) - interleukin-4 (IL-4) - t-box expressed in T cells (T-bet) - GATA-binding protein 3 (GATA-3) - splenocytes - Panax ginseng - Araliaceae
|  |